Repros Therapeutics (RPRX) Reports Q4 Loss of $0.16/Share
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.16), versus ($0.26) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.16), versus ($0.26) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.